Table 1 The relationship between PLK4 expression and clinical pathological characteristics in 85 NB patients
Characteristics | Cases, n | PLK4 | χ2 | P-value | |
---|---|---|---|---|---|
Lower, n | Higher, n | ||||
Sex | |||||
Male | 52 | 31 | 21 | 0.035 | 0.515 |
Female | 33 | 19 | 14 | ||
Age | |||||
<18 months | 14 | 10 | 4a | 1.099 | 0.228 |
≥18 months | 71 | 40 | 31 | ||
Primary site | |||||
Abdomen, cervix | 69 | 37 | 32 | 4.093 | 0.038* |
Pelvis, thorax | 16 | 13 | 3a | ||
N-myc status | |||||
Amplification | 25 | 16 | 9 | 0.037 | 0.528 |
Unamplification | 47 | 29 | 18 | ||
Serum LDH level | |||||
<1500 U/L | 59 | 46 | 13 | 29.181 | <0.001*** |
≥1500 U/L | 26 | 4 a | 22 | ||
Bone marrow metastasis | |||||
Positive | 62 | 33 | 29 | 2.964 | 0.069 |
Negative | 23 | 17 | 6 | ||
Recurrence | |||||
Yes | 41 | 18 | 23 | 7.280 | 0.006** |
No | 44 | 32 | 12 | ||
Expression level of Ki-67 | |||||
Low | 40 | 29 | 11 | 5.835 | 0.016* |
High | 45 | 21 | 24 | ||
Clinical stage of INSS | |||||
1, 2, 4s | 11 | 10 | 1a | 5.270 | 0.019 |
3, 4 | 74 | 40 | 34 |